Skip to main content
. 2011 Aug 18;1(1):151–199. doi: 10.1016/j.pervac.2011.05.006

Table 6.6.

DC vaccines and candidate vaccines licensed and in clinical development

Target Stage of development Manufacturer
Melanoma Phase I (therapeutic) Immutep
HIV Phase I (therapeutic) Baylor Research Institute
Melanoma Phase II (therapeutic) Immutep
Prostate cancer FDA licensed 2010 Dendreon

HIV, human immunodeficiency virus; FDA, Food and Drug Administration. Every effort has been made to verify the information in this table. The information included is not meant to be exhaustive but is intended to provide an overview of the subject matter.